| Literature DB >> 31188923 |
Caroline de S Araujo1, Lorrane D Brito1, Marina O Tarifa2, Nayara J Farah da Silva2, Karoline S Rodrigues3, Dalita G S M Cavalcante4, Andressa S Gomes4, Marcos A Zocoler3, Eidi Yoshihara5, Marjori L Camparoto2, Aldo E Job4, Leandra E Kerche1,2.
Abstract
This study evaluated the genotoxicity, muEntities:
Year: 2019 PMID: 31188923 PMCID: PMC6905452 DOI: 10.1590/1678-4685-GMB-2018-0038
Source DB: PubMed Journal: Genet Mol Biol ISSN: 1415-4757 Impact factor: 1.771
Figure 1Thin layer chromatography of Spondias dulcis Forst F bark ethanolic extract. SD, S. dulcis extract; QS, Quercetin standard; TA, Tannic acid standard; RS, Rutin standard; GA, Gallic acid standard.
Figure 2Evaluation of cytotoxicity in mouse bone marrow cells after acute treatment with S. dulcis bark ethanolic extract (500, 1000, and 1500 mg/kg bw) associated or not with B[a]P and CP. Calculation of PCE/(PCE+NCE) on examination of 1000 erythrocytes. Shown are means ± SD for 10 animals (male and female) from each treatment. ANOVA and Dunnett’s test (p<0.05). PCE: polychromatic erythrocyte; NCE: normochromatic erythrocyte; C: distilled water; B[a]P: benzo[a]pyrene; CP: cyclophosphamide.
Figure 3Frequency of MNPCEs in mouse bone marrow after acute treatment with three different concentrations (500, 1000, and 1500 mg/kg bw) of the S. dulcis bark ethanolic extract. Shown are the means ± SD for 10 animals (male and female) from each treatment. Statistical analysis was performed using ANOVA and Tukey’s test (p<0.05). aStatistically different from negative control group; b statistically different from B[a]P control group. cStatistically different from CP control group. MNPCE: micronucleated polychromatic erythrocyte; C: distilled water; B[a]P: benzo[a]pyrene; CP: cyclophosphamide.
Numbers of micronucleated PCEs (MNPCE) from mouse bone marrow and percent damage reduction (%R) obtained in the determination of in vivo antimutagenicity of Spondias dulcis Forst F. bark ethanolic extract at three concentrations, and the respective controls.
| Treatments (mg/kg b.w.) | No. animals | MNPCE ( | % R |
|---|---|---|---|
| C | 10 | 4.50 ± 1.05a | - |
| B[ | 10 | 20.00 ± 4.45b | - |
| CP | 10 | 22.67 ± 5.50c | - |
| 500 + B[ | 10 | 8.33 ± 1.51a | 75.29% |
| 1000 + B[ | 10 | 9.17 ± 3.25a | 69.87% |
| 1500 + B[ | 10 | 9.17 ± 1.52a | 69.87% |
| 500 + CP | 10 | 6.83 ± 0.79a | 87.18% |
| 1000 + CP | 10 | 8.00 ± 1.90a | 80.74% |
| 1500 + CP | 10 | 8.33 ± 1.96a | 78.92% |
Number of nucleoids observed in each comet class in 300 cells analyzed per treatment, and their respective mean scores when assessing the genotoxicity of Spondias dulcis at three different concentrations in mice.
| Treatment (μg/mL) | Comet Class | Damaged nucleoids | Score |
| |||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | ||||
| Control | 99 | 1 | 0 | 0 | 1 | 1 | 1.33 ± 0.58 |
| 98 | 2 | 0 | 0 | 2 | 2 | ||
| 99 | 1 | 0 | 0 | 1 | 1 | ||
| CP | 66 | 28 | 3 | 3 | 34 | 43 | 44.0 ± 6.56a |
| 66 | 30 | 4 | 0 | 34 | 38 | ||
| 55 | 39 | 6 | 0 | 45 | 51 | ||
| B[ | 87 | 13 | 0 | 0 | 13 | 13 | 12.67 ± 1.53a |
| 87 | 12 | 1 | 0 | 13 | 14 | ||
| 90 | 9 | 1 | 0 | 10 | 11 | ||
|
| |||||||
| 500 | 98 | 2 | 0 | 0 | 2 | 2 | 2.330.58b c |
| 97 | 3 | 0 | 0 | 3 | 3 | ||
| 98 | 2 | 0 | 0 | 2 | 2 | ||
| 1000 | 98 | 2 | 0 | 0 | 2 | 2 | 2.33 ± 1.53b c |
| 97 | 2 | 1 | 0 | 2 | 4 | ||
| 99 | 1 | 0 | 0 | 1 | 1 | ||
| 1500 | 99 | 1 | 0 | 0 | 1 | 1 | 2.33 ± 1.53b c |
| 97 | 2 | 1 | 0 | 3 | 4 | ||
| 98 | 2 | 0 | 0 | 2 | 2 | ||
Number of nucleoids observed in each comet class in 300 cells analyzed per treatment, and their respective mean scores when assessing the antigenotoxicity effect of Spondias dulcis at three different concentrations in mice.
| Treatment (μg/mL) | Comet Class | Damaged nucleoids | Score |
| |||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | ||||
| Control | 99 | 1 | 0 | 0 | 1 | 1 | 1.33 ± 0.58 |
| 98 | 2 | 0 | 0 | 2 | 2 | ||
| 99 | 1 | 0 | 0 | 1 | 1 | ||
| CP | 66 | 28 | 3 | 3 | 34 | 43 | 44.0 ± 6.56a |
| 66 | 30 | 4 | 0 | 34 | 38 | ||
| 55 | 39 | 6 | 0 | 45 | 51 | ||
| B[ | 87 | 13 | 0 | 0 | 13 | 13 | 12.67 ± 1.53a |
| 87 | 12 | 1 | 0 | 13 | 14 | ||
| 90 | 9 | 1 | 0 | 10 | 11 | ||
|
| |||||||
| 500 | 96 | 4 | 0 | 0 | 4 | 4 | 7.0 ± 3.0a b |
| 96 | 3 | 1 | 0 | 4 | 7 | ||
| 90 | 10 | 0 | 0 | 10 | 10 | ||
| 1000 | 99 | 1 | 0 | 0 | 1 | 1 | 3.0 ± 2.0b |
| 98 | 1 | 1 | 0 | 2 | 3 | ||
| 95 | 5 | 0 | 0 | 5 | 5 | ||
| 1500 | 95 | 4 | 1 | 0 | 5 | 6 | 5.670.58b |
| 94 | 6 | 0 | 0 | 6 | 6 | ||
| 95 | 5 | 0 | 0 | 5 | 5 | ||
|
| |||||||
| 96 | 4 | 0 | 0 | 4 | 4 | ||
| 500 | 100 | 0 | 0 | 0 | 0 | 0 | 2.3 ± 2.1c |
| 97 | 3 | 0 | 0 | 3 | 3 | ||
| 92 | 5 | 3 | 0 | 8 | 11 | ||
| 1000 | 97 | 2 | 1 | 0 | 3 | 4 | 7.0 ± 3.6a c |
| 94 | 6 | 0 | 0 | 1 | 6 | ||
| 97 | 2 | 1 | 0 | 3 | 4 | ||
| 1500 | 95 | 5 | 0 | 0 | 0 | 5 | 6.7 ± 3.8a c |
| 90 | 9 | 1 | 0 | 2 | 11 | ||
Figure 4Frequency of MNRETs in mouse peripheral blood after acute treatment with three different concentrations (500, 1000, and 1500 mg/kg bw) of the S. dulcis bark ethanolic extract. The plot shown the means ± SD for ten animals (male and female) from each treatment. Statistical analysis was performed using ANOVA and Tukey’s test (p<0.05). a Statistically different from negative control group. b Statistically different from B[a]P control group; c statistically different from CP control group. MNRET: micronucleated reticulocyte; C: distilled water; B[a]P: benzo[a]pyrene; CP: cyclophosphamide.
Numbers of micronucleated RETs (MNRET) from peripheral blood and percent damage reduction (%R) obtained in the determination of in vivo antimutagenicity of Spondias dulcis Forst F. bark ethanolic extract at three concentrations, and the respective controls.
| Treatments (mg/kg b.w.) | N. of animals | MNRET ( | % R |
|---|---|---|---|
| C | 10 | 3.33 ± 1.63a | - |
| B[a]P | 10 | 30.20 ± 10.87b | - |
| CP | 10 | 34.75 ± 4.97c | - |
| 500 + B[ | 10 | 3.75 ± 0.96a | 98.00% |
| 1000 + B[ | 10 | 5.00 ± 1.47a | 93.78% |
| 1500 + B[ | 10 | 5.33 ± 1.03a | 92.56% |
| 500 + CP | 10 | 7.80 ± 1.63a | 85.77% |
| 1000 + CP | 10 | 8.17 ± 2.40a | 84.60% |
| 1500 + CP | 10 | 10.33 ± 2.39d | 77.72% |
Figure 5Quantification of CAT (A) and GSH (B) in total blood of mouse treated with S. dulcis bark ethanolic extract (500, 1000, and 1500 mg/kg bw) associated or not to the positive controls (B[a]P and CP). Results are shown as means ± SD. a Statistically different from negative control group; b statistically different from B[a]P control group; c statistically different from CP control group. CAT: catalase; GSH: glutathione; C: distilled water; B[a]P: benzo[a]pyrene; CP: cyclophosphamide. Statistical analysis performed using ANOVA and Tukey’s test with significance threshold of p<0.05.
Figure 6Quantification of lipoperoxidation by measuring the formation of MDA, principal thiobarbituric acid-reactive specie (TBARS) (A) and GSH (B) in the liver of mouse treated with S. dulcis bark ethanolic extract (500, 1000, and 1500 mg/kg bw) associated or not to the positive controls (B[a]P and CP). Results are shown as means ± SD. a Statistically different from negative control group; b statistically different from B[a]P control group; c statistically different from CP control group. MDA: malondialdehyde; GSH: glutathione; C: distilled water; B[a]P: benzo[a]pyrene; CP: cyclophosphamide. Statistical analysis performed using ANOVA and Tukey’s test with significance threshold of p<0.05.
Figure 7Quantification of lipoperoxidation by measuring the formation of MDA, principal thiobarbituric acid-reactive specie (TBARS) (A) and GSH (B) in the kidney of mouse treated with S. dulcis bark ethanolic extract (500, 1000, and 1500 mg/kg bw) associated or not to the positive controls (B[a]P and CP). Results are shown as means ± SD. a Statistically different from negative control group; b statistically different from B[a]P control group; c statistically different from CPA control group. MDA: malondialdehyde; GSH: glutathione; C: distilled water; B[a]P: benzo[a]pyrene; CP: cyclophosphamide. Statistical analysis performed using ANOVA and Tukey’s test with significance threshold of p<0.05.